Programme – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
C:/Users/julia/biotechnologische Studenteninitiative (btS) e.V/Leipzig - ScieGuide 2019/ScieGuide final 08.08/ScieGuide070819.sl
فلسفي دافئ تحويلات بند تشابه لفة aigner et al 2011 - afsassociation.org
Focused Ultrasound Therapy
Therapeutic siRNA: State-of-the-Art and Future Perspectives | SpringerLink
Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in colon carcinoma
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Impact of medication on blood transcriptome reveals off-target regulations of beta-blockers | PLOS ONE
Inhalt. Transparenz. Forschen Lehren Heilen. Struktur & Prozess Menschen. Wichtige Kennzahlen Leistungsdaten. Einrichtungen & Ansprechpartner - PDF Free Download
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Evaluation of Colon-Specific Plasma Nanovesicles as New Markers of Colorectal Cancer
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo: Molecular Therapy - Nucleic Acids
Cell-type specific and non-redundant anti-proliferative effects of shRNA-mediated Galpha12- and Galpha13 knockdown in lung canc
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Mitarbeiter des Rudolf-Boehm-Institutes
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Zeitschrift für Naturforschung C
SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC) | Scientific Reports
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma
Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma
Type of the Paper (Article
Mitarbeiter des Rudolf-Boehm-Institutes
Accommodation – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Tau Silencing by siRNA in the P301S Mouse Model of Tauopathy
Drug Delivery by Ultrasound-Responsive Nanocarriers for Cancer Treatment
Influence of nanoparticle-mediated transfection on proliferation of primary immune cells in vitro and in vivo | PLOS ONE
